Calyx Announces Non-Brokered Private Placement

In Canada, Calyx Bio-Ventures announced the proposed non-brokered private placement of up to 5,001,000 units at a price of $0.15 per unit for cash proceeds of up to $750,150. Each unit comprises one common share and one common share purchase warrant, with the warrant entitling the holder to acquire one additional common share of the company at a price of $0.35 for a period of eighteen months from the closing of the private placement. The funds raised from the issuance of the Units will be for general working capital and corporate development purposes, and the closing of the private placement is anticipated to occur on or about June 28, subject to standard regulatory approvals.